Response to planned treatment interruptions in HIV infection varies across childhood

被引：45

作者：

Castro , Hannah ^{[1
]}

Gibb, D. M. ^{[1
]}

Compagnucci, A. ^{[1
]}

Klein, N. ^{[1
]}

Lallemant, M. ^{[1
]}

Lyall, H. ^{[1
]}

Nadal, D. ^{[1
]}

Ananworanich, J. ^{[1
]}

Babiker, A. ^{[1
]}

Bunupuradah, T. ^{[1
]}

Darbyshire, J. H. ^{[1
]}

De Rossi, A. ^{[1
]}

Tome, M. I. Gonzalez ^{[1
]}

Harper, L. ^{[1
]}

Kanjavanit, S. ^{[1
]}

Marczynska, M. ^{[1
]}

Mofenson, L. ^{[1
]}

Monpoux, F. ^{[1
]}

Moye, J. ^{[1
]}

Munoz-Fernandez, M. A. ^{[1
]}

Ngo-Giang-Huong, N. ^{[1
]}

Niehues, T. ^{[1
]}

Saidi, Y. ^{[1
]}

Walker, A. S. ^{[1
]}

Wintergerst, U. ^{[1
]}

Giaquinto, C. ^{[1
]}

机构：

[1] PENTA, Padua, Italy

来源：

AIDS | 2010年 / 24卷 / 02期

关键词：

antiretroviral therapy; clinical trial; paediatrics; randomized; treatment interruption; ACTIVE ANTIRETROVIRAL THERAPY; SHORT-TERM RISK; CD4 CELL COUNT; HIV-1-INFECTED CHILDREN; RANDOMIZED-TRIAL; DISEASE PROGRESSION; 1-INFECTED CHILDREN; PREDICTIVE-VALUE; ADULTS; DEATH;

D O I：

10.1097/QAD.0b013e328333d343

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Objective: To evaluate clinical, immunological and virological consequences of CD4-guided antiretroviral therapy (ART) planned treatment interruptions (PTIs) compared with continuous therapy in children with chronic HIV infection in the Paediatric European Network for Treatment of AIDS 11 trial. Design: This was a multicentre, 72-week, open, randomized, phase 11 trial. Methods: One hundred and nine children with HIV-RNA below 50 copies/ml and CD4% of at least 30% (2-6 years) or at least 25% and CD4 cell count of at least 500 cells/mu l (7-15 years) were randomized to continuous therapy (53) or PTI (56). In PTI, ART was restarted if confirmed CD4% was less than 20% or more than 48 weeks had been spent off ART. The primary outcome was Centers for Disease Control and Prevention (CDC) stage C event, death or CD4% less than 15% (and CD4 cell count less than 200 cells/mu l for children aged 7-15years). Results: At baseline, median (interquartile range) age was 9 (6-12) years, CD4% 37% (33-41), CD4 cell count 966 (793-11258)cells/mu l, nadir CD41/0 before combination ART 18% (10-27), time on ART 6 (3-6) years and 26% were CDC stage C. After median (range) 130 (33-180) weeks of follow-up, 4 versus 48% of time was spent off ART in continuous therapy and PTI, respectively. No child died or had a new CDC stage C event; one (2%) continuous therapy versus four (7%) PTI children had a primary outcome based on CD4%/cell count (P=0.2). Lower nadir CD4% predicted faster CD4% decline after stopping ART. Younger age and higher nadir CD4% predicted being off ART for at least 48 weeks and better CD4% recovery following PTI. Conclusion: In this first paediatric trial of PTI, there were no serious clinical outcomes. Younger children had better CD4% recovery after PTIs. Immunology substudies and long-term follow-up in Paediatric European Network for Treatment of AIDS 11 trial are ongoing. Further research into the role of treatment interruption in children is required, particularly, as guidelines now recommend early ART for all infected infants. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins

引用

页码：231 / 241

页数：11

共 26 条

[1] CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1:: results of the Staccato randomised trial [J].

Ananworanich, Jintanat ;

Gayet-Ageron, Angele ;

Le Braz, Michelle ;

Prasithsirikul, Wisit ;

Chetchotisakd, Ploenchan ;

Kiertiburanakul, Sasisopin ;

Munsakul, Warangkana ;

Raksakulkarn, Phitsanu ;

Tansuphasawasdikul, Somboon ;

Sirivichayakul, Sunee ;

Cavassini, Matthias ;

Karrer, Urs ;

Genne, Daniel ;

Nueesch, Reto ;

Vernazza, Pietro ;

Bernasconi, Enos ;

Leduc, Dominic ;

Satchell, Claudette ;

Yerly, Sabine ;

Perrin, Luc ;

Hill, Andrew ;

Perneger, Thomas ;

Phanuphak, Praphan ;

Furrer, Hansjakob ;

Cooper, David ;

Ruxrungtham, Kiat ;

Hirschel, Bernard .

LANCET, 2006, 368 (9534) :459-465

[2]

[Anonymous], 1994, MMWR Recomm Rep, V43, P1

[3]

[Anonymous], DIV AIDS TABL GRAD S

[4]

BOBAT R, 2006, 16 INT AIDS C 13 18

[5] Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children [J].

Cressey, Tim R. ;

Green, Hannah ;

Khoo, Saye ;

Treluyer, Jean-Marc ;

Compagnucci, Alexandra ;

Saidi, Yacine ;

Lallemant, Marc ;

Gibb, Diana M. ;

Burger, David M. ;

Aboulker, J-P ;

Babiker, A. ;

Blanche, S. ;

Bohlin, A. -B. ;

Butler, K. ;

Castelli-Gattinara, G. ;

Clayden, P. ;

Compagnucci, A. ;

Darbyshire, J. H. ;

Debre, M. ;

de Groot, R. ;

della Negra, M. ;

Duicelescu, D. ;

Giaquinto, C. ;

Gibb, D. M. ;

Grosch-Worner, I. ;

Kind, C. ;

Lallemant, M. ;

Levy, J. ;

Lyall, H. ;

Marczynska, M. ;

Mellado Pena, M. J. ;

Nadal, D. ;

Niehues, T. ;

Peckham, C. ;

Ramos Amador, J. T. ;

Rosado, L. ;

Rudin, C. ;

Scherpbier, H. J. ;

Sharland, M. ;

Stevanovic, M. ;

Tovo, P. A. ;

Tudor-Williams, G. ;

Valerius, N. ;

Walker, A. S. ;

Wintergerst, U. ;

Harper, L. ;

Klein, N. ;

Mofenson, L. ;

Moye, J. ;

Jacqz-Aigrain, E. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (10) :1601-1608

[6] CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial):: a randomised trial [J].

Danel, Christine ;

Moh, Raoul ;

Minga, Albert ;

Anzian, Amani ;

Ba-Gomis, Olivier ;

Kanga, Constance ;

Nzunetu, Gustave ;

Gabillard, Delphine ;

Rouet, Francois ;

Sorho, Souleymane ;

Chaix, Marie-Laure ;

Eholie, Serge ;

Menan, Herve ;

Sauvageot, Delphine ;

Bissagnene, Emmanuel ;

Salamon, Roger ;

Anglaret, Xavier .

LANCET, 2006, 367 (9527) :1981-1989

[7] Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial [J].

De Rossi, A ;

Walker, AS ;

Klein, N ;

De Forni, D ;

King, D ;

Gibb, DM .

JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (03) :312-320

[8]

Dunn DT, 2006, AIDS, V20, P1289, DOI 10.1097/01.aids.0000232237.20792.68

[9] Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults [J].

Dunn, David ;

Woodburn, Patrick ;

Duong, Trinh ;

Peto, Julian ;

Phillips, Andrew ;

Gibb, Di ;

Porter, Kholoud .

JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (03) :398-404

[10]

Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9

← 1 2 3 →